Israeli circumcision device provokes union outcry in South Africa

Israeli circumcision device provokes union outcry in South Africa

JOHANNESBURG (Reuters) - South Africa may turn to an Israeli circumcision device to reduce the number of young males who die in botched initiation ceremonies, provoking an outcry from union allies of the ruling party who support sanctions against the Jewish state. Every year, dozens of teenaged South African males die of blood loss or infection in traditional circumcision practices during the initiation ceremonies which are a key rite of passage to manhood, especially among the Xhosa nation. ...

Modi orders Indian officials to clean loos on Gandhi's birthday

By Manoj Kumar NEW DELHI (Reuters) - India's new Prime Minister Narendra Modi has ordered government officers to work on Mahatma Gandhi's birthday, a national holiday, to clean ministries - including toilets - in a nationwide cleanliness drive. Modi plans to honor the independence hero by launching on Thursday the Clean India campaign, which aims to solve the country's sanitation and rubbish problems within five years to mark the 150th anniversary of Gandhi's Oct 2 birthday. ...

Former Washington Post editor Ben Bradlee in hospice care: wife

WASHINGTON (Reuters) - Former Washington Post Executive Editor Ben Bradlee, who oversaw the newspaper's coverage of the Watergate scandal in the 1970s, is in hospice care, his wife said. Bradlee, 93, is suffering from Alzheimer's disease and sleeps much of the day, Sally Quinn told C-Span in an interview aired late on Sunday. "He does know who I am, yes. We actually called in hospice care this week," said Quinn, a religion columnist for the Post. Hospice care provides specialized medical treatment for terminally or seriously ill patients. ...

Roche, GSK melanoma pill combinations look similar in showdown

By Ben Hirschler MADRID (Reuters) - Rival two-pill combinations for melanoma from Roche and GlaxoSmithKline had similarly good results in separate clinical trials, leaving doctors with little to choose between the two skin cancer courses. The latest findings will fuel a wider debate about the optimal treatment of melanoma as a new generation of immune-stimulating injections offers an alternative way to fight the deadliest form of skin cancer. ...

Study makes the case for letting teenagers sleep in

Everyone knows sleep is important for teenagers, but a new study says that ensuring they get enough of it could call for a later start to the school day.

Kamada extends emphysema drug deal with Baxter through 2017

JERUSALEM (Reuters) - Israeli drugmaker Kamada said on Monday it extended an agreement with Baxter International to supply a drug to treat emphysema through 2017. Under the extended agreement, Kamada said it will receive $26 million in additional revenues of Glassia, a proprietary drug to treat clinically evident emphysema in adults due to severe alpha-1-antitrypsin (AAT) deficiency. ...

Hundreds of firms join global hunt for copycat biotech drugs

By Ben Hirschler (Reuters) - Hundreds of companies around the world are chasing an emerging market for cheaper copies of costly biotech drugs, with more than 700 so-called biosimilars now in development or already approved, according to a major study of the sector. Biotech medicines - made from proteins and other large molecules - account for six of the 10 biggest-selling drugs in the world today, led by AbbVie's $12 billion-a-year rheumatoid arthritis injection Humira. ...

Study makes the case for letting teenagers sleep in

Everyone knows sleep is important for teenagers, but a new study says that ensuring they get enough of it could call for a later start to the school day.

Tonix Pharma's pain drug fails mid-stage study

By Amrutha Penumudi (Reuters) - Tonix Pharmaceuticals Holding Corp said its lead drug for pain management failed the main goal of a mid-stage study, sending its down by more than half in early trading. The drug, TNX-102, is being tested to treat fibromyalgia, a chronic syndrome characterized by widespread pain and lack of sleep. The treatment failed the main goal of reducing pain experienced by patients by the 12th week of the trial, Tonix said. "I think it's a major setback. Don't forget, the drug is already available as a generic. To me, that means the data had to be outstanding. ...

Roche, GSK melanoma pill combinations look similar in showdown

By Ben Hirschler MADRID (Reuters) - Rival two-pill combinations for melanoma from Roche and GlaxoSmithKline had similarly good results in separate clinical trials, leaving doctors with little to choose between the two skin cancer courses. The latest findings will fuel a wider debate about the optimal treatment of melanoma as a new generation of immune-stimulating injections offers an alternative way to fight the deadliest form of skin cancer. ...

Israeli circumcision device provokes union outcry in South Africa

JOHANNESBURG (Reuters) - South Africa may turn to an Israeli circumcision device to reduce the number of young males who die in botched initiation ceremonies, provoking an outcry from union allies of the ruling party who support sanctions against the Jewish state. Every year, dozens of teenaged South African males die of blood loss or infection in traditional circumcision practices during the initiation ceremonies which are a key rite of passage to manhood, especially among the Xhosa nation. ...

You are reading an article about Israeli circumcision device provokes union outcry in South Africa and you can find this article in url https://we-care-you.blogspot.com/2014/09/israeli-circumcision-device-provokes.html,You can copy paste and use the article Israeli circumcision device provokes union outcry in South Africa , may this is very interesting for you and others ,but don't forget to take this link Israeli circumcision device provokes union outcry in South Africa for article source, Thanks.